Evidence map›Paper›PMID 29071814›Full record

ArticleAnnals of laboratory medicine2018

Extensively Drug-Resistant Escherichia coli Sequence Type 1642 Carrying an IncX3 Plasmid Containing the blaKPC-2 Gene Associated with Transposon Tn4401a.

Seri Jeong, Jung Ok Kim, Eun Jeong Yoon, Il Kwon Bae, Woonhyoung Lee, Hyukmin Lee, Yongjung Park, Kyungwon Lee, Seok Hoon Jeong

Open access · diamondAbstract read
In one paragraph

Article in Annals of laboratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Population characteristics of pathogenicFrontiers in microbiology · 2024
    Article
  5. Antimicrobial resistance in food-associatedBioscience of microbiota, food and health · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Species Transferability ofJournal of microbiology and biotechnology · 2020
    Article
  10. A Clinical Extensively-Drug Resistant (XDR)Frontiers in microbiology · 2020
    Article
  11. A Novel KPC Variant KPC-55 inFrontiers in microbiology · 2020
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Seri JeongDepartment of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea.
Jung Ok KimDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Eun Jeong YoonDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Il Kwon BaeDepartment of Dental Hygiene, College of Medical and Life Science, Shilla University, Busan, Korea.
Woonhyoung LeeDepartment of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea.
Hyukmin LeeDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Yongjung ParkDepartment of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Ilsan, Korea.
Kyungwon LeeDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Seok Hoon JeongDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea. kscpjsh@yuhs.ac.
Yonsei University · KRKosin University · KRNational Health Insurance Service · KRSilla University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtensively drug-resistant (XDR) Enterobacteriaceae carrying the bla(KPC) gene have emerged as a major global therapeutic concern. The purpose of this study was to analyze the complete sequences of plasmids from KPC-2 carbapenemase-producing XDR Escherichia coli sequence type (ST) 1642 isolates.

methodsWe performed antimicrobial susceptibility testing, PCR, multilocus sequence typing (MLST), and whole-genome sequencing to characterize the plasmid-mediated KPC-2-producing E. coli clinical isolates.

resultsThe isolates were resistant to most available antibiotics, including meropenem, ampicillin, ceftriaxone, gentamicin, and ciprofloxacin, but susceptible to tigecycline and colistin. The isolates were identified as the rare ST1642 by MLST. The isolates carried four plasmids: the first 69-kb conjugative IncX3 plasmid harbors bla(KPC-2) within a truncated Tn4401a transposon and bla(SHV-11) with duplicated conjugative elements. The second 142-kb plasmid with a multireplicon consisting of IncQ, IncFIA, and IncIB carries bla(TEM-1b) and two class 1 integrons. This plasmid also harbors a wide variety of additional antimicrobial resistance genes including aadA5, dfrA17, mph(A), sul1, tet(B), aac(3')-IId, strA, strB, and sul2.

conclusionsThe complete sequence analysis of plasmids from an XDR E. coli strain related to persistent infection showed the coexistence of a bla(KPC-2)-carrying IncX3-type plasmid and a class 1 integron-harboring multireplicon, suggesting its potential to cause outbreaks. Of additional clinical significance, the rare ST1642, identified in a cat, could constitute the source of human infection.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDNA Transposable ElementsDrug Resistance, BacterialEscherichia coliEscherichia coli ProteinsGenotypeHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsPolymerase Chain ReactionWhole Genome SequencingAnti-Bacterial Agentsbeta-LactamasesDNA Transposable ElementsEscherichia coli Proteinsbla(KPC)Escherichia coliIncX3ST1642Tn4401a

Identifiers

PMID29071814
PMCPMC5700142
OpenAlexW2766907748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.